SCHEMBL4637682

SCHEMBL4637682

CC(C)(C)C1CN(C(=O)O)CCc2cc(N)ccc21

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NR1H2 P55055 1/20 0.46
DRD1 P21728 5/20 0.36
DRD2 P14416 3/20 0.36
DRD5 P21918 1/20 0.36
BRD4 O60885 1/20 0.34
ATAD2 Q6PL18 1/20 0.34
HTR1A P08908 1/20 0.33
HTR2A P28223 1/20 0.33
CA1 P00915 2/20 0.33
CA2 P00918 2/20 0.33
CA9 Q16790 2/20 0.33
CA14 Q9ULX7 2/20 0.33
MMP1 P03956 1/20 0.33
MMP2 P08253 1/20 0.33
MMP9 P14780 1/20 0.33
MMP12 P39900 1/20 0.33
MMP14 P50281 1/20 0.33
MMP15 P51511 1/20 0.33
MMP16 P51512 1/20 0.33
MMP26 Q9NRE1 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2124644 0.86 ESR2 (0.45) DRD1DRD2DRD5MMP1MMP2
SCHEMBL19638276 0.85 CAMK2A (0.41) ESR2ESR1HDAC6
SCHEMBL5162115 0.84 MAPK14 (0.37) NR1H2CA1CA2CA9CA14
SCHEMBL5669983 0.82 ESR2 (0.40) DRD1DRD2HTR2AESR2ESR1
SCHEMBL5551729 0.82 ESR1 (0.47) DRD1DRD2DRD5CA1CA2
SCHEMBL5170173 0.82 ALDH1A1 (0.34) MTNR1BGRIN1GRIN2B
SCHEMBL5170182 0.81 HCRTR1 (0.32) DRD1DRD2ESR2ESR1MTNR1B
SCHEMBL2120755 0.81 DPP4 (0.38) DRD2CA1CA2CA9CA14
SCHEMBL5552127 0.81 DRD1 (0.46) NR1H2DRD1DRD2DRD5HTR2A
SCHEMBL2312465 0.81 HTR1A (0.43) HTR1AHTR2ABAZ2B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1951712-A2 CHEMICAL COMPOUNDS GLAXO GROUP LIMITED (GB) 2008-08-06 EP disclosed
WO-2007059952-A2 1-BENZAZEPINE-3-SULFONYLAMINO-2-PYRRLORIDONES AS FACTOR XA INHIBITORS GLAXO GROUP LIMITED (GB) 2007-05-31 WO disclosed
EP-1773844-A1 COMPOUNDS HAVING AFFINITY FOR THE DOPAMINE D3 RECEPTOR AND USES THEREOF IN MEDICINE GLAXO GROUP LIMITED (GB) 2007-04-18 EP disclosed
EP-1751163-A2 COMPOUNDS HAVING AFFINITY FOR DOPAMINE D3 RECEPTOR AND USES THEREOF GLAXO GROUP LIMITED (GB) 2007-02-14 EP disclosed
EP-1713778-A1 BENZAZEPINE DERIVATIVES AS HISTAMINE H3 ANTAGONISTS GLAXO GROUP LIMITED (GB) 2006-10-25 EP disclosed
WO-2006002928-A1 COMPOUNDS HAVING AFFINITY FOR THE DOPAMINE D3 RECEPTOR AND USES THEREOF IN MEDICINE GLAXO GROUP LIMITED (GB) 2006-01-12 WO disclosed
WO-2005118549-A2 COMPOUNDS HAVING AFFINITY FOR DOPAMINE D3 RECEPTOR AND USES THEREOF GLAXO GROUP LIMITED (GB) 2005-12-15 WO disclosed
WO-2005058837-A1 BENZAZEPINE DERIVATIVES AS HISTAMINE H3 ANTAGONISTS GLAXO GROUP LIMITED (GB) 2005-06-30 WO disclosed